Lixisenatide (ADLYXIN) Phonetic pronunciation: LIX i SEN a tide / ad LIX in Mnemonic: Add licks in a Tide (Pod) Year of release: 2016 Price range: $690$710 FDA-approved for: Type 2 diabetes Mechanism: GLP-1 receptor agonist Available doses: 10 mcg, 20 mcg Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble Lixisenatide (Adlyxin) is the newer exendin-based GLP analog
All GLP-1s are clinically-tested, stimulant-free, and non-habit forming
At its therapeutic doses, only a small amount of APAP is metabolized by the hepatocyte cytochrome P450 enzyme system into N -acetyl- p -benzoquinone imine (NAPQI), a major toxic metabolite
10.1111/dom.12639 [DOI] [PMC free article] [PubMed] [Google Scholar] 131.Kapitza C, Zdravkovic M, Hindsberger C, Flint A
[34] Bone-derived food products are high in fat, free of carbs, and keto-friendly